NDC 60505-6230
Paclitaxel protein-bound particles for injectable suspension (albumin-bound)
Paclitaxel
Paclitaxel protein-bound particles for injectable suspension (albumin-bound) is a Intravenous Injection, Powder, Lyophilized, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Paclitaxel.
| Product ID | 60505-6230_7325d86b-947f-41a1-bf26-7e988fd17b2e |
| NDC | 60505-6230 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Paclitaxel protein-bound particles for injectable suspension (albumin-bound) |
| Generic Name | Paclitaxel |
| Dosage Form | Injection, Powder, Lyophilized, For Suspension |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-04-01 |
| Marketing Category | NDA AUTHORIZED GENERIC / |
| Application Number | NDA021660 |
| Labeler Name | Apotex Corp. |
| Substance Name | PACLITAXEL |
| Active Ingredient Strength | 100 mg/20mL |
| Pharm Classes | Microtubule Inhibition [PE], Microtubule Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |